Picture Campus Berlin-Buch at BIO2023 BerlinBioCube Start-up Center 650x100px

News > All

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1668 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. 2023-05-15
Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg. 2023-05-12
DiogenX S.A.S.. (5/10/23). "Press Release: DiogenX Raises €27.5M Series A Financing to Advance Its First-in-Class Regenerative Treatment for Type 1 Diabetes Towards Clinical Development". Marseille. 2023-05-10
Alia Therapeutics S.r.l.. (5/9/23). "Press Release: Alia Therapeutics Appoints Adel Nada as Independent Board Director". Milan. 2023-05-09
Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg. 2023-05-05
Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan. 2023-05-05
Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA. 2023-04-26
Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin. 2023-04-18
Alia Therapeutics S.r.l.. (4/17/23). "Press Release: Alia Therapeutics Secures €4.4 Million Seed Financing Extension Led by Sofinnova Partners". Milan. 2023-04-17
Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. 2023-04-13
Calida Therapeutics S.A.S.. (4/6/23). "Press Release: French Biotech Calida Therapeutics Launches with Seed Funding, Leveraging US Academic Research in Thrombo-inflammatory Disorders". Paris. 2023-04-06
Scorpion Therapeutics, Inc.. (4/4/23). "Press Release: Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer". Bost 2023-04-04
AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". 2023-04-03
Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen. 2023-03-31
Galapagos N.V.. (3/30/23). "Press Release: Galapagos and Novalix Enter into an Integrated Drug Discovery Collaboration". Mechelen & Strasbourg. 2023-03-30
Deepc GmbH. (3/28/23). "Press Release: Digital Medicine Pioneer, Deepc, Announces €12 Million Series A Round Led by Sofinnova Partners". 2023-03-28
Sofinnova Partners. (3/28/23). "Press Release: Sofinnova Partners Launches Digital Medicine Strategy. VC to Back Startups at the Intersection of Biology, Data and Computation". Paris. 2023-03-28
Sofinnova Partners. (3/28/23). "Press Release: Kiro, Cutting-edge Digital Medicine Company, Raises €13.8 Million in Series A Funding Led by Sofinnova Partners". Paris. 2023-03-28
Sofinnova Partners. (3/28/23). "Press Release: BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures to Unlock Drug-bacteria Interactions". London. 2023-03-28
ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. 2023-03-27
Mediar Therapeutics Inc.. (3/15/23). "Press Release: Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies". Cambridge, MA. 2023-03-15
AlgoTherapeutix S.A.S.. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes. 2023-03-14
Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ. 2023-03-13
Iktos S.A.S.. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne. 2023-03-09
Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel. 2023-03-07
AdBio Partners S.A.S.. (2/23/23). "Press Release: AdBio Partners Appoints Geoffroy de Ribains as Managing Partner". Paris. 2023-02-23
Avilar Therapeutics, Inc.. (2/16/23). "Press Release: Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders". Waltham, MA. 2023-02-16
Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris. 2023-02-16
Biper Therapeutics S.A.S.. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg. 2023-02-14
Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse. 2023-02-10
Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg. 2023-02-07
Sensorion S.A.. (1/31/23). "Press Release: Sensorion and Eveon Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments into the Inner Ear". Montpellier. 2023-01-31
Toulouse White Biotech (TWB). (1/31/23). "Press Release: TWB Announces a Strategic Partnership with Canadian Multinational Premier Tech". Toulouse. 2023-01-31
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. 2023-01-23
InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. 2023-01-19
PinCell S.r.l.. (1/19/23). "Press Release: PinCell Announces the Development of a Key Transgenic Mouse Model and the Appointment of Dr. Antonino Amato as CEO". Milan. 2023-01-19
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
InDevR, Inc.. (1/17/23). "Press Release: InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux". Boulder, CO. 2023-01-17
Sanofi S.A.. (1/11/23). "Press Release: Sanofi Ventures Announces Multi-year Capital Commitment from Sanofi, Increasing Evergreen Fund to $750M". Paris. 2023-01-11
CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. 2023-01-10
Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. 2023-01-10
Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. 2023-01-09
Volta Medical. (1/5/23). "Press Release: Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced". Marseille. 2023-01-05
ErVaccine Technologies S.A.. (1/5/23). "Press Release: ErVaccine Closes a €4.5 Million Financing Round and Prepares to Start Clinical Trial with Its First Therapeutic Cancer Vaccine in 2023". Lyon. 2023-01-05
Cellectis S.A.. (12/29/22). "Press Release: Mayflower Bioventures Launches Its First Spin-Out, Primera Therapeutics, in Strategic Collaboration with Cellectis to Develop a Gene Editing Platform to Treat Mitochondrial Diseases". New York, NY. 2022-12-29
Cellectis S.A.. (12/28/22). "Press Release: Cellectis Secures a €40 Million Credit Facility from the European Investment Bank to Support its Research, Development and Innovation Activities". Paris. 2022-12-28
Atara Biotherapeutics, Inc.. (12/20/22). "Press Release: Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty". Thousand Oaks, CA. 2022-12-20
Atara Biotherapeutics, Inc.. (12/19/22). "Press Release: Atara Biotherapeutics’ Ebvallo (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD". Thousand Oaks, CA & Castres. 2022-12-19
Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. 2022-12-17
Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg. 2022-12-15
Oncodesign Precision Medicine S.A.. (12/15/22). "Press Release: OPM and Servier Launch "FederAidd", an International Virtual Campus for Open Innovation to Accelerate and Make the Drug Discovery Process more Reliable Thanks to Artificial Intelligence". Pa 2022-12-15
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. 2022-11-30
Biomemory S.A.S.. (11/28/22). "Press Release: Biomemory Raises 5 Million Euros Seed Investment to Advance Its Cutting-edge DNA Digital Data Storage Solution". Paris. 2022-11-28
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. 2022-11-14
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. 2022-11-11
Insilico Medicine. (11/8/22). "Press Release: Insilico Medicine Signs Strategic Research Collaboration with Sanofi Worth up to $1.2 Billion". New York, NY. 2022-11-08
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. 2022-11-08
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. 2022-11-07
Theranexus S.A.. (10/20/22). "Press Release: Theranexus and Inserm Transfert Sign a Strategic Alliance to Identify Advanced Therapy Drug Candidates for Rare Neurological Diseases". Lyon. 2022-10-20
Univercells S.A.. (10/19/22). "Press Release: Univercells Raises € 44 Million in First Close of Its Series D". Brussels. 2022-10-19
Aqemia S.A.S.. (10/19/22). "Press Release: Aqemia Raises €30M to Scale its Deep Physics and AI Enabled Drug Discovery Pipeline". Paris. 2022-10-19
Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. 2022-10-17
Mablink Bioscience S.A.S.. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon. 2022-10-14
Matchpoint Therapeutics, Inc.. (10/14/22). "Press Release: Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases". Cambridge, MA. 2022-10-14
Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. 2022-10-11
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
ArchiMed S.A.S.. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist". 2022-10-07
OSE Immunotherapeutics S.A.. (10/7/22). "Press Release: OSE Immunotherapeutics Appoints Nicolas Poirier as Chief Executive Officer". Nantes. 2022-10-07
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. 2022-10-07
Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". 2022-10-06
Owkin. (10/4/22). "Press Release: Owkin Appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer". 2022-10-04
Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. 2022-10-04
Aurobac Therapeutics S.A.S.. (10/4/22). "Press Release: Aurobac Therapeutics, the Joint Venture Recently Created by Boehringer Ingelheim, Evotec and bioMérieux, Appoints Florence Séjourné as Chief Executive Officer". Lyon. 2022-10-04
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. 2022-09-30
Quinten Health. (9/20/22). "Press Release: Quinten Health Closes Its Financing Round to Advance Disease Modeling Platforms and Virtual Twins in Real-world". Paris. 2022-09-20
ECBF Management GmbH. (9/20/22). "Press Release: ECBF Leads €10m Series B Investment in Digital Pest Monitoring Provider Trapview to Expand Its Sustainable Agriculture Technology Portfolio". Luxembourg. 2022-09-20
Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. 2022-09-19
Evotec SE. (9/16/22). "Press Release: Evotec Initiates Ground-breaking for New Biologics Facility J.POD Toulouse, France (EU)". Hamburg. 2022-09-16
Tricares S.A.S.. (9/15/22). "Press Release: Tricares Raises €47m in a First Closing of Its Series C Financing to Fund Further Development of Minimally Invasive Treatment for Tricuspid Regurgitation". Paris & Munich. 2022-09-15
Tridek-One S.A.S.. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
SparingVision S.A.S.. (9/14/22). "Press Release: SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases". 2022-09-14
Standing Ovation S.A.S.. (9/14/22). "Press Release: Foodtech Startup Standing Ovation Closes a €12M Series A Financing Round to Accelerate the Development of Its Animal-free Casein and Cheese Substitute Production Process". Paris. 2022-09-14
Owkin. (9/13/22). "Press Release: Owkin and 12 Partners Launch $14 Million NIH Project to Allow Doctors to Spot Cancer, Depression and other Diseases from the Human Voice". 2022-09-13
Scienion AG. (9/13/22). "Press Release: Scienion and Cellenion Launch the proteoCHIP LF 48, for Label-free Single-cell Proteomics Sample Preparation on the cellenONE platform". Berlin & Lyon. 2022-09-13
Immatics N.V.. (9/10/22). "Press Release: Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022". Houston, TX & Tübingen. 2022-09-10
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. 2022-09-08
genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. 2022-09-08
NLC Ventures Netherlands B.V.. (9/8/22). "Press Release: AIDO, an NLC venture, Has Made It Its Mission to Bring more Control to Physicians Performing Endoscopic Procedures and Lower the Threshold to Expand Complex Interventions". 2022-09-08
Lesaffre & Cie.. (9/7/22). "Press Release: Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-throughput Genome Editing and Synthetic Biology". Paris & San Francisco, CA. 2022-09-07
Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris. 2022-09-02
AH Diagnostics A/S. (9/1/22). "Press Release: AH Diagnostics AS Acquires DiuVita Diagnostics AS". 2022-09-01
Carbios S.A.. (9/1/22). "Press Release: Carbios Strengthens Executive Committee with the Appointment of Pascal Bricout as Chief Strategy & Financial Officer". Clermont-Ferrand. 2022-09-01
AlgoTherapeutix S.A.S.. (9/1/22). "Press Release: AlgoTx Announces Initiation of Global Phase 2 Clinical Trial of ATX01 for the Relief of Pain in Chemotherapy-induced Peripheral Neuropathy in Adults". Suresnes. 2022-09-01
Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. 2022-08-18
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page


Picture EasyFairs Connect in Pharma 2023 Geneva Speakers 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch l2 at BIO2023 BerlinBioCube Start-up Center 650x300px

» top